!Sample_title = BRAF-V600E melanoma_451Lu_parental_drug senstive!Sample_geo_accession = GSM1199178!Sample_status = Public on Apr 21 2014!Sample_submission_date = Aug 01 2013!Sample_last_update_date = Apr 21 2014!Sample_type = genomic!Sample_channel_count = 2!Sample_source_name_ch1 = 451Lu_drug sensitive!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = cell line: BRAF-V600E melanoma 451Lu cell line!Sample_characteristics_ch1 = genotype/variation: parental (drug sensitive)!Sample_characteristics_ch1 = tissue origin: lung metastasis!Sample_characteristics_ch1 = age: 24 hrs!Sample_treatment_protocol_ch1 = Drug resistant sublines were generated by chronic exposure to escaliting doses of trametinib!Sample_growth_protocol_ch1 = Melanoma cells are grown in DMEM + 5% FBS  as previously described (Villanueva, et al. Cancer Cell. 2010 Dec 14;18(6):683-95 - PMID: 21156289)!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = Cells were scrapped, pelleted, and genomic DNA extracted using Qiagen genomic DNA purification kit.!Sample_label_ch1 = Cy5!Sample_label_protocol_ch1 = Experimental and Control DNA was labeled using Invitrogen's BioPrime Total for Agilent aCGH following standard labeling and purification protocol.!Sample_source_name_ch2 = reference sample!Sample_organism_ch2 = Homo sapiens!Sample_taxid_ch2 = 9606!Sample_characteristics_ch2 = sample type: Female Control DNA from Promega!Sample_treatment_protocol_ch2 = Drug resistant sublines were generated by chronic exposure to escaliting doses of trametinib!Sample_growth_protocol_ch2 = Melanoma cells are grown in DMEM + 5% FBS  as previously described (Villanueva, et al. Cancer Cell. 2010 Dec 14;18(6):683-95 - PMID: 21156289)!Sample_molecule_ch2 = genomic DNA!Sample_extract_protocol_ch2 = Cells were scrapped, pelleted, and genomic DNA extracted using Qiagen genomic DNA purification kit.!Sample_label_ch2 = Cy3!Sample_label_protocol_ch2 = Experimental and Control DNA was labeled using Invitrogen's BioPrime Total for Agilent aCGH following standard labeling and purification protocol.!Sample_hyb_protocol = Hybridization was performed following Agilent's Array-based CGH for Genomic DNA Analysis - Enzymatic Labeling protocol, using reagents supplied in the Agilent Oligo aCGH Hybridization Kit.!Sample_scan_protocol = Scanned on an Agilent G2565CA scanner.!Sample_description = 451Lu!Sample_data_processing = Agilent Feature Extraction Software (version 10.5.1.1) was used for background subtraction and linear normalization.!Sample_platform_id = GPL9777!Sample_contact_name = Katherine,,Nathanson!Sample_contact_email = knathans@exchange.upenn.edu!Sample_contact_institute = Perelman School of Medicine at the University of Pennsylvania!Sample_contact_address = 421 Curie Blvd!Sample_contact_city = Philadelphia!Sample_contact_state = PA!Sample_contact_zip/postal_code = 19103!Sample_contact_country = USA!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1199nnn/GSM1199178/suppl/GSM1199178_451Lu.txt.gz!Sample_series_id = GSE49430!Sample_data_row_count = 420288